Skip to main content
    T

    Tvardi Therapeutics, Inc. (TVRD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.01
    -0.09 (-8.18%)

    Market Cap: $14.70M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Tvardi Therapeutics, Inc. (TVRD) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Tvardi Therapeutics (TVRD) has a latest price of $1.01 on Nov 17, 2026, 82.2% below its 52-week high of $5.69. Its price fell 74.9% over the past 12 months. The month-end price fell 99.7% over the 10 years through Oct 2026, a compound annual decline of 43.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $935.75 in Nov 2019 and its lowest $0.79 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TVRD with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TVRD.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 46.3%, and over 6 months it fell 72.8%. The month-end price fell 98.3% over the 3 years through Oct 2026, a compound annual decline of 74.3%.

    PeriodChange
    1 month+4.1%
    3 months-46.3%
    6 months-72.8%
    12 months-74.9%
    12 months, with dividends-74.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-98.3%-74.3%
    5 years-99.9%-73.5%
    10 years-99.7%-43.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 31.8%, and its weakest was 2023, when it fell 93.1%.

    YearCloseChange
    2026 through Oct 2026$0.79-81.6%
    2025$4.30-76.6%
    2024$18.36-31.4%
    2023$26.76-93.1%
    2022$386.83-11.8%
    2021$438.70-19.5%
    2020$544.95-6.1%
    2019$580.25+23.9%
    2018$468.23+6.2%
    2017$440.86+31.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 15.7% below its 50-day average of $1.20 and 60.6% below its 200-day average of $2.56.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.01
    52-week high$5.69-82.2%
    52-week low$0.77+30.7%
    50-day average$1.20-15.7%
    200-day average$2.56-60.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.2%.

    MeasureValue
    1-year beta1.81
    Largest fall, 1 year-84.1%
    Largest fall, 3 years-98.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TVRD

    What is TVRD's 1-year price change?

    Tvardi Therapeutics's price fell 74.9% over the past 12 months. With dividends included, the 12-month total return was -74.9%.

    What is TVRD's 5-year price change?

    Tvardi Therapeutics's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.5%. These figures leave out dividends.

    What is TVRD's 52-week high and low?

    Tvardi Therapeutics's 52-week high is $5.69 and its 52-week low is $0.77. Its latest price of $1.01 on Nov 17, 2026 is 82.2% below the high.

    What is TVRD's beta?

    Tvardi Therapeutics's 1-year beta against the S&P 500 is 1.81, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 84.1%.

    Is the TVRD chart free?

    Yes. Advanced Charting for TVRD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.